266 related articles for article (PubMed ID: 8944337)
1. The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders.
Chen W; Zouboulis CC; Orfanos CE
Dermatology; 1996; 193(3):177-84. PubMed ID: 8944337
[TBL] [Abstract][Full Text] [Related]
2. Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis.
Thiboutot DM; Knaggs H; Gilliland K; Hagari S
Br J Dermatol; 1997 Feb; 136(2):166-71. PubMed ID: 9068725
[TBL] [Abstract][Full Text] [Related]
3. Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.
Nguyen QH; Chen T; Wang X; Chen Y; Chien P
Int J Dermatol; 1995 Oct; 34(10):720-5. PubMed ID: 8537164
[TBL] [Abstract][Full Text] [Related]
4. Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
Azzouni F; Zeitouni N; Mohler J
J Drugs Dermatol; 2013 Feb; 12(2):e30-5. PubMed ID: 23377402
[TBL] [Abstract][Full Text] [Related]
5. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.
Pelletier G; Luu-The V; Huang XF; Lapointe H; Labrie F
J Urol; 1998 Aug; 160(2):577-82. PubMed ID: 9679931
[TBL] [Abstract][Full Text] [Related]
6. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
Spinucci G; Pasquali R
Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
[TBL] [Abstract][Full Text] [Related]
7. Characterization, expression, and immunohistochemical localization of 5 alpha-reductase in human skin.
Luu-The V; Sugimoto Y; Puy L; Labrie Y; Lopez Solache I; Singh M; Labrie F
J Invest Dermatol; 1994 Feb; 102(2):221-6. PubMed ID: 8106751
[TBL] [Abstract][Full Text] [Related]
8. 5alpha-reductase activity in the prostate.
Steers WD
Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
[TBL] [Abstract][Full Text] [Related]
9. Is increased 5 alpha-reductase activity a primary phenomenon in androgen-dependent skin disorders?
Dijkstra AC; Goos CM; Cunliffe WJ; Sultan C; Vermorken AJ
J Invest Dermatol; 1987 Jul; 89(1):87-92. PubMed ID: 3598204
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
11. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro.
Seiffert K; Seltmann H; Fritsch M; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):141-8. PubMed ID: 17326010
[TBL] [Abstract][Full Text] [Related]
13. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
14. Sexual hormones in human skin.
Zouboulis CC; Chen WC; Thornton MJ; Qin K; Rosenfield R
Horm Metab Res; 2007 Feb; 39(2):85-95. PubMed ID: 17326004
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of 5alpha-reductase inhibitors.
Cilotti A; Danza G; Serio M
J Endocrinol Invest; 2001 Mar; 24(3):199-203. PubMed ID: 11314752
[TBL] [Abstract][Full Text] [Related]
16. Role of 5 alpha-reductase in health and disease.
Randall VA
Baillieres Clin Endocrinol Metab; 1994 Apr; 8(2):405-31. PubMed ID: 8092979
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of 5alpha-reductase isozymes in acne lesions and normal skin.
Thiboutot D; Bayne E; Thorne J; Gilliland K; Flanagan J; Shao Q; Light J; Helm K
Arch Dermatol; 2000 Sep; 136(9):1125-9. PubMed ID: 10987868
[TBL] [Abstract][Full Text] [Related]
18. Androgens in women: Androgen-mediated skin disease and patient evaluation.
Bienenfeld A; Azarchi S; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
J Am Acad Dermatol; 2019 Jun; 80(6):1497-1506. PubMed ID: 30312644
[TBL] [Abstract][Full Text] [Related]
19. Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats.
Ye F; Imamura K; Imanishi N; Rhodes L; Uno H
Skin Pharmacol; 1997; 10(5-6):288-97. PubMed ID: 9449168
[TBL] [Abstract][Full Text] [Related]
20. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
